Search for: "OMNICARE CLINICAL RESEARCH, INC." Results 1 - 8 of 8
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
3 Mar 2010, 10:53 am by Ray Mullman
Revenue from Omnicare's clinical research business slipped to $34.3 million from $49.1 million. [read post]
19 Oct 2011, 10:14 am by Amber Walsh
Others include Nautic Partners’ acquisition of Omnicare Clinical Research, Thomas Lee Partners’ buyout of InVentive Health, Avista Capital Partners and Ontario Teachers’ Pension Plan’s acquisition of INC Research and the Warburg Pincus buyout of ReSearch Pharmaceutical Services. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
As the authors report below, they conclude from their research that the suits against biotech companies are not likelier to survive dismissal motions. [read post]
4 Nov 2013, 9:56 pm by Jon Gelman
”J&J Subsidiary Janssen Pleads Guilty to Misbranding Antipsychotic DrugIn a criminal information filed today in the Eastern District of Pennsylvania, the government charged that, from March 3, 2002, through Dec. 31, 2003, Janssen Pharmaceuticals Inc., a J&J subsidiary, introduced the antipsychotic drug Risperdal into interstate commerce for an unapproved use, rendering the product misbranded. [read post]